本综述（原文为观察性研究）评估了Control-IQ自动胰岛素输送（AID）系统在沙特儿童及青少年胰岛素依赖型糖尿病患者中的疗效与安全性。研究证实，从每日多次注射（MDI）转为Control-IQ治疗6个月后，糖化血红蛋白（HbA1c）及胰岛素剂量均显著降低，达标范围内 ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its commercial launch of the t:slim X2™ insulin pump ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance of ...

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its commercial launch of the t:slim X2™ insulin pump ...